Business Context and Reporting Period
Palisade Bio, Inc. (PALI) filed a Form 8-K on May 12, 2026, to announce financial results for the three months ended March 31, 2026. The company is incorporated in Delaware and trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained in the press release attached as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. Investors must refer to the attached press release for comparative financial data.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the referenced press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2026 revenue and net loss figures.
- Verify cash balance and burn rate to assess runway.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if there were any changes in debt obligations or equity financing activities during the quarter.